February 21, 2020
Video
A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Bringing Hope and Healing to Patients With Cancer
Discussing the Importance of Genetic Counseling in Women’s Cancer
Addressing Barriers to Care, Improving Access in Women’s Cancers
Transitioning from Active Care to Survivorship in Women’s Cancer